Clinical Trials Logo

Filter by:
NCT ID: NCT05325619 Completed - Gynecologic Disease Clinical Trials

Evaluation of the Rate of Consultations in Gynecological Emergencies Under "Non-urgent" Management

URGO_CARE
Start date: March 23, 2022
Phase:
Study type: Observational

The difference between the demand and the current medical supply poses a real public health problem in terms of the organization of health care systems. For several years in France, there has been an increase in the number of consultations in emergency services, particularly gynaecological ones. The two causes put forward are a change in user behavior with an increase in requests for rapid but "non-urgent" care and the inadequacy of the supply of care in the private sector. Few studies have been carried out concerning gynaecological emergencies, unlike general emergencies. The aim of this study is to measure the frequency of consultations in gynaecological emergencies for non-emergency reasons. The interest of this study is therefore mainly on the optimization of the care system with the emphasis on the city-hospital network in the management of these patients.

NCT ID: NCT05325450 Recruiting - Hearing Loss Clinical Trials

Optimization of Hearing Performance in the Subject Implanted

OPERSA
Start date: May 18, 2023
Phase: N/A
Study type: Interventional

In the past two decades, the selection criteria for cochlear implantation have been greatly relaxed so that about 60-70% of present cochlear implant (CI) candidates have significant residual hearing in their contralateral ear. However, contralateral hearing is often not considered in rehabilitation programs, mainly due to the lack of scientific evidence on the role it may play. The present project aims to better understand the mechanisms of perceptual learning of CI-processed speech after implantation and to develop and test rehabilitation strategies for CI users.

NCT ID: NCT05325086 Completed - Clinical trials for Chronic Respiratory Disease

Effect on Quality of Life of Adapted Information in Pulmonary Rehabilitation in Chronic Respiratory Disease Patients

Start date: April 5, 2022
Phase: N/A
Study type: Interventional

The purpose of the clinical study is to study the effect of health-related quality of Life of information aimed at reducing the impact of a personality trait (openness to experiences) identified as a risk of non-response to pulmonary rehabilitation in patients with chronic respiratory diseases. This study will determine if a specific information focusing on characteristics of openness to experiences personality trait will lead to better benefits than a general information.

NCT ID: NCT05325047 Completed - Epilepsy Clinical Trials

Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy: A Case Study

REPREO SCED
Start date: September 20, 2022
Phase: N/A
Study type: Interventional

Out of 30,000 new cases per year in France, 30% of epileptic patients are drug-resistant. Neurosurgery, which consists in resecting the epileptogenic zone, is the only chance of cure. In the case of temporal epilepsy of the language-dominant hemisphere (TLE), this procedure presents a high risk of increasing cognitive difficulties and may even be contraindicated for this reason alone. The difficulties found are impairments in lexical access (anomia) and verbal memory and affect more than 60% of patients. Preoperative cognitive rehabilitation could influence brain plasticity mechanisms but there are currently no recommendations on this topic. In this context, a speech rehabilitation procedure specific to the needs of ELTPR patients was developed. Investigators rely on cognitive hypotheses explaining the disorders but also on models of rehabilitation-induced neural plasticity likely to improve cognitive reserve before surgery. Investigators hypothesize that preoperative cognitive language rehabilitation in ELTPR patients may decrease surgical risk and improve postoperative language prognosis. The main objective is to demonstrate the efficacy of preoperative speech therapy on language performance and to evaluate possible protective effects on postoperative language prognosis. Single case study following the Single Case Experimental Design (SCED) methodology involving the prior definition of the following elements: a repeated measure of the target behavior (naming abilities), the sequential introduction of an intervention (speech therapy), whose effect will be evaluated according to SCED specific analysis and statistics (visual analysis, Tau -U, randomized tests). Investigators expect patients' naming performance to be stable before the introduction of speech therapy. It is expected that patients will progress in the trained words from the beginning of speech therapy. Finally, in the postoperative period, investigators predict that for the trained words, patients will show performances superior or equal to the pre-rehabilitation period. This result would support a protective effect of preoperative speech therapy.

NCT ID: NCT05324852 Terminated - Emergence Delirium Clinical Trials

AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine

AGINASAL
Start date: April 9, 2023
Phase: Phase 3
Study type: Interventional

This study is a non-inferiority phase III randomized trial evaluating the effect of intranasal midazolam versus intramuscular loxapine on the rapid tranquilization of agitated patient in emergency department. Intranasal midazolam is safe and may allow a management of extreme agitation state and prevent adverse effects.

NCT ID: NCT05323734 Active, not recruiting - Clinical trials for Tuberous Sclerosis Complex

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Start date: April 1, 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3, global, double-blind, randomized, placebo-controlled study of adjunctive GNX treatment in children and adults with TSC-related epilepsy. The study consists of a 4-week prospective Baseline phase, defined as the first 28 days following screening, followed by a double-blind phase consisting of a 4-week titration period (Day 1 to Day 28) and a 12-week maintenance period (Day 29 to Week 16).

NCT ID: NCT05323656 Active, not recruiting - Clinical trials for Squamous Cell Carcinoma of Head and Neck

A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Start date: April 6, 2022
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version 1.1 (RECIST v1.1) in recurrent or metastatic SCCHN patients treated with setanaxib and pembrolizumab versus patients treated with placebo and pembrolizumab.

NCT ID: NCT05323604 Completed - Sarcopenia Clinical Trials

Impact of Sarcopenia Using an Easy Psoas Area Measurement

ISEPAM
Start date: March 1, 2022
Phase:
Study type: Observational

The purpose of this study is to compare the post-operative course in patients suffering from sarcopenia who had colorectal surgery for cancer. Our primary outcome is the comparaison of the length of hospital stay in sarcopenic and non sarcopenic patients.

NCT ID: NCT05323591 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France

PARROTFISH
Start date: May 3, 2022
Phase:
Study type: Observational

An observational study to describe the effectiveness, safety, and patient-reported outcomes (PROs) in participants with moderate to severe active rheumatoid arthritis (RA) in France receiving filgotinib in real-world setting.

NCT ID: NCT05323552 Recruiting - Hernia, Inguinal Clinical Trials

Hernia Repair Using the Totally ExtraPeritoneal (TEP) Laparoscopic Approach Without Curare and Without Orotracheal Intubation.

FREE_CURARE
Start date: November 21, 2022
Phase:
Study type: Observational

Laparoscopic treatment of inguinal hernia with the totally extraperitoneal approach (TEP) is indicated for simple and bilateral inguinal hernias. It consists of placing a large prosthesis in the posterior position by direct access to the extra-peritoneal space. This prosthesis is interposed between the defective wall and the peritoneum. Unlike the transperitoneal laparoscopic method, the strictly extraperitoneal approach reduces complications related to contact with the intestinal loops and preserves the peritoneal layer intact. TEP approach is traditionally performed under general anesthesia with curare and orotracheal intubation. In the study, we would like to assess this intervention without curare and without standard orotracheal intubation but with a laryngeal mask airway to permit ventilation.